Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,612,114 papers from all fields of science
Search
Sign In
Create Free Account
cloricromen
Known as:
cloricromene
, 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarboxylmethoxycoumarin
, Acetic acid, ((8-chloro-3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)-, ethyl ester
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
AD-6 (8-chlorocarbochromen)
Broader (2)
Chromonar
Platelet Aggregation Inhibitors
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.
R. Pignatello
,
Nadia Ricupero
,
C. Bucolo
,
F. Maugeri
,
A. Maltese
,
G. Puglisi
AAPS PharmSciTech
2006
Corpus ID: 43295947
The purpose of this study was to improve the stability of cloricromene (AD6) in ophthalmic formulations and its drug availability…
Expand
1997
1997
Cloricromene Reduces Myocardial Infarct Size in Rabbits When Administered During the Early Reperfusion Period
D. Zvara
,
H. J. Galaska
,
+5 authors
E. Kim
Anesthesia and Analgesia
1997
Corpus ID: 19485480
Cloricromene is a coumarin derivative without anticoagulant activities that has recently been found to decrease myocardial…
Expand
1995
1995
Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
D. Altavilla
,
F. Squadrito
,
+5 authors
A. Caputi
American Journal of Physiology
1995
Corpus ID: 20102911
Splanchnic arteries were clamped for 45 min to induce splanchnic artery occlusion (SAO) shock in anesthetized rats. Sham-operated…
Expand
1995
1995
Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury
G. Calapai
,
F. Squadrito
,
A. Rizzo
,
M. Marciano
,
G. Campo
,
A. Caputi
Naunyn-Schmiedeberg's Archives of Pharmacology
1995
Corpus ID: 7409478
The effects of different doses (0.25, 0.5, 1 and 2 mg/kg/i.p.) of cloricromene, a coumarine derivative, have been investigated on…
Expand
1994
1994
Beneficial effects of cloricromene in ischemic reperfused myocardium.
J. Milei
,
R. Ferreira
,
D. Grana
,
R. Beigelman
,
R. Cirillo
The Cardiology
1994
Corpus ID: 46782020
Cloricromene (Clo) has been used to prevent myocardial damage after transient occlusion of the circumflex coronary artery (Cx…
Expand
1993
1993
Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets.
M. Stasi
,
P. Gresele
,
+5 authors
G. Goracci
Journal of lipid mediators
1993
Corpus ID: 38176688
The coumarin derivative, cloricromene, an antithrombotic drug previously indicated as AD6, is known to inhibit the release of…
Expand
1991
1991
Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene.
A. Zatta
,
M. Prosdocimi
,
G. Bazzoni
,
E. Dejana
,
A. del Maschio
European Journal of Pharmacology
1991
Corpus ID: 7223436
1990
1990
Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline.
A. del Maschio
,
G. Bazzoni
,
A. Zatta
,
Z. M. Chen
,
E. Dejana
,
M. Prosdocimi
European Journal of Pharmacology
1990
Corpus ID: 4605435
1987
1987
The increase of the openings of the surface-connected canalicular system in weakly stimulated platelets is prevented by a carbochromen derivative. A computerized morphometric analysis of freeze…
G. Bianciardi
,
P. Toti
,
G. Weber
Pharmacological Research Communications
1987
Corpus ID: 33442828
1986
1986
Ultrastructural modifications of the platelet plasma membrane in vascular diseases and the effect of a carbochromen derivative as studied by freeze-fracture and computer measurement.
G. Bianciardi
,
A. Vittoria
,
+4 authors
G. Weber
Atherosclerosis
1986
Corpus ID: 24801279
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE